Donor hemovigilance: Delayed vasovagal Donor hemovigilance: Delayed vasovagal reaction with injury in a blood donor reaction with injury in a blood donor Sir, We report a case of delayed vasovagal reaction in a 19-year-old male blood donor of severe grade and defi nite imputability as per the classifi cation of working group on complications related to blood donation (International Society of Blood Transfusion working party on Hemovigilance and European Hemovigilance Network, 2008) in a blood donor qualifying the blood donor selection criteria as per the standard operating procedure of our department based on the Drugs and Cosmetics Act of India. The blood donor was brought back to the donation venue 1½ h post blood donation by his colleagues. The donor was found to be responsive and reported that he was sitting in the garden adjoining hostel and consequent upon standing in order to walk to his room, experienced light headedness, profuse sweating and then fainted. On examination, the pulse rate was 62/min, regular and blood pressure of 110/68 mm of Hg. There was no h/o of projectile vomiting, no nystagmus. The left thumb was swollen and painful, which is consistent with a post blood donation delayed vasovagal loss of consciousness, followed by fall. Closed reduction with k-wire fi xation of base of distal phalanx was done after X-ray [ Figure 1 ]. Donor was asymptomatic; the nail bed showed early new nail recovery on follow-up. The donor hemovigilance arm of a national hemovigilance system should be based on standardized reporting formats and review initiatives being implemented to reduce adverse reactions. Reporting, monitoring and evaluation of blood donor reactions and the outcome of interventions could help generate evidence for formulating strategies that could have an impact to decrease adverse donor reactions in order to retain willingness to donate blood. Undetermined blood loss due Undetermined blood loss due to accidental injury and its management to accidental injury and its management in a male patient of classical Bombay (Oh) in a male patient of classical Bombay (Oh) phenotype in a hospital in the remote part phenotype in a hospital in the remote part of east India of east India Sir, Absence of A, B, and H antigen on red cell surface, commonly known as Bombay (Oh) phenotype, is an extremely rare blood group type as it is found in 1 in 10,000 individual in India and 1/1,000,000 individuals in Europe.
[1] The presence of anti-H antibody in the serum of Oh phenotype makes the transfusion of identical Oh phenotype blood necessary in such patients. [2] Bombay phenotype can be either classical Bombay or para-Bombay, with classical Bombay phenotype more common in India. [3] Characterization of Bombay phenotype in the recipient as well as in donor is extremely important for transfusion management. Furthermore, recipients requiring multiple units of Oh blood during an emergency, as the case mentioned here, can be a challenge for transfusion service providers.
A 25-year-old male patient presented to the emergency department due to inability to transfuse cross match compatible blood elsewhere. Laboratory investigations revealed requirement of 3 units of Oh blood urgently. Pretransfusion testing in the form of blood grouping and antibody screening indicated recipient to be Oh phenotype. Further testing with anti-H lectin and saliva testing confi rmed the recipient to be of Oh phenotype. Direct coomb's test, indirect coomb's test, dithiothreitol treatment and titration with thermal amplitude testing confi rmed the recipient to be of classical Oh phenotype [ Table 1 ]. Screening fi rst degree relatives revealed classical Oh phenotype in elder brother. Several places in different states of India were contacted telephonically, but most of them had no information of even a single Oh donor in spite of several cases reported in the country. [1] Two more units of Oh Rh positive blood were arranged from the western part of India situated about 1953 km from our hospital [ Figure 1 ]. Recipient had to wait for 18 h till the blood units were arranged. This experience of ours clearly indicates that some times, even 1 unit of blood from family relatives is not suffi cient for management of acutely bleeding (Oh) patients. Differentiating Bombay phenotype into classical and para-bombay would be of great help, as procuring blood for a para-bombay phenotype patient is relatively easier. [4] Also transfusion of blood donated from fi rst degree family relative may be associated with life-threatening complication such as transfusion-associated graft-versus-host disease. [5] In order to deal with such typical situation, a vigorous effort should be taken to establish rare donor registry program at state as well as national level. Clinical effi cacy and applications of therapeutic Clinical effi cacy and applications of therapeutic plasma exchange: A tertiary care center plasma exchange: A tertiary care center experience from Jammu experience from Jammu Sir, Therapeutic plasma exchange (TPE) commonly used in disorders where immune etiology has been implicated that is, Guillain -Barre' syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis (MG), multiple sclerosis and acute disseminated encephalomyelitis. [1] This study is a retrospective study carried out in the Department of Transfusion Medicine, Government Medical College, Jammu from July 2009 to February 2011. The list of patients was obtained from the TPE log-book of the apheresis units in our facility. TPE was carried out on continuous fl ow Fenwal CS-3000 plus cell separator requiring double-venous access. All patients were classified according to Hughes functional grading scores . [2] A total of 22 patients underwent 71 TPE procedures. The study group included 13 males and 9 females in the ratio of 1.4:1. The mean age was 36.8 years, with age ranging from (17 to 75 years). Of 22 patients, there were 18 cases of GB syndrome (81.8%), two cases of MG (9%), one case each of thrombotic thrombocytopenic purpura (TTP) (4.5%) and chronic demyelinating polyneuropathy (4.5%). The details of procedures are described in Table 1 .
In 18 cases of GB syndrome, complete response was noted in 11 cases (61%), partial response in 3 cases (16%), no response in 4 cases (22%) with an overall response rate of 77% at the end of 10 days follow-up period. One case of CIDP underwent six procedures and recovered completely. MG patient with antibody negative case showed good response after five procedures and weaned off from ventilator. One case of TTP underwent nine procedures, showed good response with lactate dehydrogenase (LDH) <250 U/L, platelet count 2.3 lakhs/cu mm after seven procedures, two of which were performed in our center. However, relapsed after 7 months with intracerebral hemorrhage, LDH 2833 U/L, and platelet count 68,000/cu mm. The last two procedures were incomplete due to poor peripheral venous access, though, planned for central venous access, but were not successful due to marked edema of the neck and ultimately patient died This study showed encouraging response rates in neurological diseases. Cochrane systematic meta-analysis reported that TPE was the only treatment for GBS and found to be superior to supportive treatment. Furthermore, TPE was more benefi cial when applied within the fi rst 7 days of disease. Many studies showed encouraging results in cases of TTP who underwent TPE. [3] TPE appears to be just as benefi cial as intravenous immunoglobulin therapy in patients with MG. [4] To conclude, in our experience TPE is safe and effective mode of treatment.
